Assessing Bleeding Risk and Outcomes in Left Main Percutaneous Coronary Intervention: The Prognostic Role of the PRECISE-DAPT Score - Scorecard - MDSpire
Clinical Scorecard: Assessing Bleeding Risk and Outcomes in Left Main Percutaneous Coronary Intervention: The Prognostic Role of the PRECISE-DAPT Score
At a Glance
Category
Detail
Condition
Left Main Coronary Artery Disease
Key Mechanisms
Increased myocardial territory at risk and potential for adverse cardiovascular outcomes.
Target Population
Patients undergoing left main percutaneous coronary intervention (PCI).
Care Setting
High-volume tertiary medical center.
Key Highlights
Dual antiplatelet therapy (DAPT) is critical post-PCI to reduce ischemic events.
The PRECISE-DAPT score estimates bleeding risk in PCI populations.
High bleeding risk (HBR) patients have worse clinical outcomes post-LM PCI.
Guideline-Based Recommendations
Diagnosis
Use the PRECISE-DAPT score to assess bleeding risk.
Management
Implement DAPT based on clinical presentation and physician judgment.
Monitoring & Follow-up
Monitor for major adverse cardiac and cerebrovascular events (MACCE) and bleeding outcomes.
Risks
Consider risks of prolonged DAPT, especially in patients with high bleeding risk.
Patient & Prescribing Data
Patients undergoing first left main PCI without prior CABG or STEMI.
DAPT regimen and duration should be tailored to individual patient risk profiles.
Clinical Best Practices
Conduct multidisciplinary Heart Team evaluations for complex cases.
Utilize standardized tools like the PRECISE-DAPT score for risk assessment.
A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.
